Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension periodRaja Padidela,Michael P. Whyte,Francis H. Glorieux,Craig F. Munns,Leanne M. Ward,Ola Nilsson,Anthony A. Portale,Jill H. Simmons,Noriyuki Namba,Hae Il Cheong,Pisit Pitukcheewanont,Etienne Sochett,Wolfgang Hoegler,Koji Muroya,Gary S. Gottesman,Andrew Biggin,Farzana Perwad,Angela Williams,Annabel Nixon,Wei Sun,Angel Chen,Alison Skrinar,Erik A. ImelHORMONE RESEARCH IN PAEDIATRICS（2022）引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
